Global Friedreich Ataxia Drug Market Growth 2024-2031

Report ID: 1503626 | Published Date: Jan 2025 | No. of Page: 110 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Scope of the Report
    1.1 Market Introduction
    1.2 Years Considered
    1.3 Research Objectives
    1.4 Market Research Methodology
    1.5 Research Process and Data Source
    1.6 Economic Indicators
    1.7 Currency Considered
2 Executive Summary
    2.1 World Market Overview
        2.1.1 Global Friedreich Ataxia Drug Annual Sales 2017-2028
        2.1.2 World Current & Future Analysis for Friedreich Ataxia Drug by Geographic Region, 2017, 2022 & 2028
        2.1.3 World Current & Future Analysis for Friedreich Ataxia Drug by Country/Region, 2017, 2022 & 2028
    2.2 Friedreich Ataxia Drug Segment by Type
        2.2.1 ADVM-063
        2.2.2 AGIL-FA
        2.2.3 BHV-4157
        2.2.4 BVA-202
        2.2.5 Others
    2.3 Friedreich Ataxia Drug Sales by Type
        2.3.1 Global Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)
        2.3.2 Global Friedreich Ataxia Drug Revenue and Market Share by Type (2017-2022)
        2.3.3 Global Friedreich Ataxia Drug Sale Price by Type (2017-2022)
    2.4 Friedreich Ataxia Drug Segment by Application
        2.4.1 Clinic
        2.4.2 Hospital
        2.4.3 Others
    2.5 Friedreich Ataxia Drug Sales by Application
        2.5.1 Global Friedreich Ataxia Drug Sale Market Share by Application (2017-2022)
        2.5.2 Global Friedreich Ataxia Drug Revenue and Market Share by Application (2017-2022)
        2.5.3 Global Friedreich Ataxia Drug Sale Price by Application (2017-2022)
3 Global Friedreich Ataxia Drug by Company
    3.1 Global Friedreich Ataxia Drug Breakdown Data by Company
        3.1.1 Global Friedreich Ataxia Drug Annual Sales by Company (2020-2022)
        3.1.2 Global Friedreich Ataxia Drug Sales Market Share by Company (2020-2022)
    3.2 Global Friedreich Ataxia Drug Annual Revenue by Company (2020-2022)
        3.2.1 Global Friedreich Ataxia Drug Revenue by Company (2020-2022)
        3.2.2 Global Friedreich Ataxia Drug Revenue Market Share by Company (2020-2022)
    3.3 Global Friedreich Ataxia Drug Sale Price by Company
    3.4 Key Manufacturers Friedreich Ataxia Drug Producing Area Distribution, Sales Area, Product Type
        3.4.1 Key Manufacturers Friedreich Ataxia Drug Product Location Distribution
        3.4.2 Players Friedreich Ataxia Drug Products Offered
    3.5 Market Concentration Rate Analysis
        3.5.1 Competition Landscape Analysis
        3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    3.6 New Products and Potential Entrants
    3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Friedreich Ataxia Drug by Geographic Region
    4.1 World Historic Friedreich Ataxia Drug Market Size by Geographic Region (2017-2022)
        4.1.1 Global Friedreich Ataxia Drug Annual Sales by Geographic Region (2017-2022)
        4.1.2 Global Friedreich Ataxia Drug Annual Revenue by Geographic Region
    4.2 World Historic Friedreich Ataxia Drug Market Size by Country/Region (2017-2022)
        4.2.1 Global Friedreich Ataxia Drug Annual Sales by Country/Region (2017-2022)
        4.2.2 Global Friedreich Ataxia Drug Annual Revenue by Country/Region
    4.3 Americas Friedreich Ataxia Drug Sales Growth
    4.4 APAC Friedreich Ataxia Drug Sales Growth
    4.5 Europe Friedreich Ataxia Drug Sales Growth
    4.6 Middle East & Africa Friedreich Ataxia Drug Sales Growth
5 Americas
    5.1 Americas Friedreich Ataxia Drug Sales by Country
        5.1.1 Americas Friedreich Ataxia Drug Sales by Country (2017-2022)
        5.1.2 Americas Friedreich Ataxia Drug Revenue by Country (2017-2022)
    5.2 Americas Friedreich Ataxia Drug Sales by Type
    5.3 Americas Friedreich Ataxia Drug Sales by Application
    5.4 United States
    5.5 Canada
    5.6 Mexico
    5.7 Brazil
6 APAC
    6.1 APAC Friedreich Ataxia Drug Sales by Region
        6.1.1 APAC Friedreich Ataxia Drug Sales by Region (2017-2022)
        6.1.2 APAC Friedreich Ataxia Drug Revenue by Region (2017-2022)
    6.2 APAC Friedreich Ataxia Drug Sales by Type
    6.3 APAC Friedreich Ataxia Drug Sales by Application
    6.4 China
    6.5 Japan
    6.6 South Korea
    6.7 Southeast Asia
    6.8 India
    6.9 Australia
    6.10 China Taiwan
7 Europe
    7.1 Europe Friedreich Ataxia Drug by Country
        7.1.1 Europe Friedreich Ataxia Drug Sales by Country (2017-2022)
        7.1.2 Europe Friedreich Ataxia Drug Revenue by Country (2017-2022)
    7.2 Europe Friedreich Ataxia Drug Sales by Type
    7.3 Europe Friedreich Ataxia Drug Sales by Application
    7.4 Germany
    7.5 France
    7.6 UK
    7.7 Italy
    7.8 Russia
8 Middle East & Africa
    8.1 Middle East & Africa Friedreich Ataxia Drug by Country
        8.1.1 Middle East & Africa Friedreich Ataxia Drug Sales by Country (2017-2022)
        8.1.2 Middle East & Africa Friedreich Ataxia Drug Revenue by Country (2017-2022)
    8.2 Middle East & Africa Friedreich Ataxia Drug Sales by Type
    8.3 Middle East & Africa Friedreich Ataxia Drug Sales by Application
    8.4 Egypt
    8.5 South Africa
    8.6 Israel
    8.7 Turkey
    8.8 GCC Countries
9 Market Drivers, Challenges and Trends
    9.1 Market Drivers & Growth Opportunities
    9.2 Market Challenges & Risks
    9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
    10.1 Raw Material and Suppliers
    10.2 Manufacturing Cost Structure Analysis of Friedreich Ataxia Drug
    10.3 Manufacturing Process Analysis of Friedreich Ataxia Drug
    10.4 Industry Chain Structure of Friedreich Ataxia Drug
11 Marketing, Distributors and Customer
    11.1 Sales Channel
        11.1.1 Direct Channels
        11.1.2 Indirect Channels
    11.2 Friedreich Ataxia Drug Distributors
    11.3 Friedreich Ataxia Drug Customer
12 World Forecast Review for Friedreich Ataxia Drug by Geographic Region
    12.1 Global Friedreich Ataxia Drug Market Size Forecast by Region
        12.1.1 Global Friedreich Ataxia Drug Forecast by Region (2023-2028)
        12.1.2 Global Friedreich Ataxia Drug Annual Revenue Forecast by Region (2023-2028)
    12.2 Americas Forecast by Country
    12.3 APAC Forecast by Region
    12.4 Europe Forecast by Country
    12.5 Middle East & Africa Forecast by Country
    12.6 Global Friedreich Ataxia Drug Forecast by Type
    12.7 Global Friedreich Ataxia Drug Forecast by Application
13 Key Players Analysis
    13.1 Adverum Biotechnologies Inc
        13.1.1 Adverum Biotechnologies Inc Company Information
        13.1.2 Adverum Biotechnologies Inc Friedreich Ataxia Drug Product Offered
        13.1.3 Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.1.4 Adverum Biotechnologies Inc Main Business Overview
        13.1.5 Adverum Biotechnologies Inc Latest Developments
    13.2 BioMarin Pharmaceutical Inc.
        13.2.1 BioMarin Pharmaceutical Inc. Company Information
        13.2.2 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product Offered
        13.2.3 BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.2.4 BioMarin Pharmaceutical Inc. Main Business Overview
        13.2.5 BioMarin Pharmaceutical Inc. Latest Developments
    13.3 Biovista Inc.
        13.3.1 Biovista Inc. Company Information
        13.3.2 Biovista Inc. Friedreich Ataxia Drug Product Offered
        13.3.3 Biovista Inc. Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.3.4 Biovista Inc. Main Business Overview
        13.3.5 Biovista Inc. Latest Developments
    13.4 Cardero Therapeutics Inc
        13.4.1 Cardero Therapeutics Inc Company Information
        13.4.2 Cardero Therapeutics Inc Friedreich Ataxia Drug Product Offered
        13.4.3 Cardero Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.4.4 Cardero Therapeutics Inc Main Business Overview
        13.4.5 Cardero Therapeutics Inc Latest Developments
    13.5 Catabasis Pharmaceuticals, Inc.
        13.5.1 Catabasis Pharmaceuticals, Inc. Company Information
        13.5.2 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product Offered
        13.5.3 Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.5.4 Catabasis Pharmaceuticals, Inc. Main Business Overview
        13.5.5 Catabasis Pharmaceuticals, Inc. Latest Developments
    13.6 Forward Pharma A/S
        13.6.1 Forward Pharma A/S Company Information
        13.6.2 Forward Pharma A/S Friedreich Ataxia Drug Product Offered
        13.6.3 Forward Pharma A/S Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.6.4 Forward Pharma A/S Main Business Overview
        13.6.5 Forward Pharma A/S Latest Developments
    13.7 Ixchel Pharma LLC
        13.7.1 Ixchel Pharma LLC Company Information
        13.7.2 Ixchel Pharma LLC Friedreich Ataxia Drug Product Offered
        13.7.3 Ixchel Pharma LLC Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.7.4 Ixchel Pharma LLC Main Business Overview
        13.7.5 Ixchel Pharma LLC Latest Developments
    13.8 Pfizer Inc
        13.8.1 Pfizer Inc Company Information
        13.8.2 Pfizer Inc Friedreich Ataxia Drug Product Offered
        13.8.3 Pfizer Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.8.4 Pfizer Inc Main Business Overview
        13.8.5 Pfizer Inc Latest Developments
    13.9 ProQR Therapeutics NV
        13.9.1 ProQR Therapeutics NV Company Information
        13.9.2 ProQR Therapeutics NV Friedreich Ataxia Drug Product Offered
        13.9.3 ProQR Therapeutics NV Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.9.4 ProQR Therapeutics NV Main Business Overview
        13.9.5 ProQR Therapeutics NV Latest Developments
    13.10 RaNA Therapeutics Inc
        13.10.1 RaNA Therapeutics Inc Company Information
        13.10.2 RaNA Therapeutics Inc Friedreich Ataxia Drug Product Offered
        13.10.3 RaNA Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.10.4 RaNA Therapeutics Inc Main Business Overview
        13.10.5 RaNA Therapeutics Inc Latest Developments
    13.11 Reata Pharmaceuticals Inc
        13.11.1 Reata Pharmaceuticals Inc Company Information
        13.11.2 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product Offered
        13.11.3 Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.11.4 Reata Pharmaceuticals Inc Main Business Overview
        13.11.5 Reata Pharmaceuticals Inc Latest Developments
    13.12 Retrotope Inc
        13.12.1 Retrotope Inc Company Information
        13.12.2 Retrotope Inc Friedreich Ataxia Drug Product Offered
        13.12.3 Retrotope Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.12.4 Retrotope Inc Main Business Overview
        13.12.5 Retrotope Inc Latest Developments
    13.13 Takeda
        13.13.1 Takeda Company Information
        13.13.2 Takeda Friedreich Ataxia Drug Product Offered
        13.13.3 Takeda Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.13.4 Takeda Main Business Overview
        13.13.5 Takeda Latest Developments
    13.14 STATegics Inc
        13.14.1 STATegics Inc Company Information
        13.14.2 STATegics Inc Friedreich Ataxia Drug Product Offered
        13.14.3 STATegics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.14.4 STATegics Inc Main Business Overview
        13.14.5 STATegics Inc Latest Developments
    13.15 Voyager Therapeutics Inc
        13.15.1 Voyager Therapeutics Inc Company Information
        13.15.2 Voyager Therapeutics Inc Friedreich Ataxia Drug Product Offered
        13.15.3 Voyager Therapeutics Inc Friedreich Ataxia Drug Sales, Revenue, Price and Gross Margin (2020-2022)
        13.15.4 Voyager Therapeutics Inc Main Business Overview
        13.15.5 Voyager Therapeutics Inc Latest Developments
14 Research Findings and Conclusion

List of Tables
    Table 1. Friedreich Ataxia Drug Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
    Table 2. Friedreich Ataxia Drug Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
    Table 3. Major Players of ADVM-063
    Table 4. Major Players of AGIL-FA
    Table 5. Major Players of BHV-4157
    Table 6. Major Players of BVA-202
    Table 7. Major Players of Others
    Table 8. Global Friedreich Ataxia Drug Sales by Type (2017-2022) & (K Pcs)
    Table 9. Global Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)
    Table 10. Global Friedreich Ataxia Drug Revenue by Type (2017-2022) & ($ million)
    Table 11. Global Friedreich Ataxia Drug Revenue Market Share by Type (2017-2022)
    Table 12. Global Friedreich Ataxia Drug Sale Price by Type (2017-2022) & (USD/Pcs)
    Table 13. Global Friedreich Ataxia Drug Sales by Application (2017-2022) & (K Pcs)
    Table 14. Global Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)
    Table 15. Global Friedreich Ataxia Drug Revenue by Application (2017-2022)
    Table 16. Global Friedreich Ataxia Drug Revenue Market Share by Application (2017-2022)
    Table 17. Global Friedreich Ataxia Drug Sale Price by Application (2017-2022) & (USD/Pcs)
    Table 18. Global Friedreich Ataxia Drug Sales by Company (2020-2022) & (K Pcs)
    Table 19. Global Friedreich Ataxia Drug Sales Market Share by Company (2020-2022)
    Table 20. Global Friedreich Ataxia Drug Revenue by Company (2020-2022) ($ Millions)
    Table 21. Global Friedreich Ataxia Drug Revenue Market Share by Company (2020-2022)
    Table 22. Global Friedreich Ataxia Drug Sale Price by Company (2020-2022) & (USD/Pcs)
    Table 23. Key Manufacturers Friedreich Ataxia Drug Producing Area Distribution and Sales Area
    Table 24. Players Friedreich Ataxia Drug Products Offered
    Table 25. Friedreich Ataxia Drug Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
    Table 26. New Products and Potential Entrants
    Table 27. Mergers & Acquisitions, Expansion
    Table 28. Global Friedreich Ataxia Drug Sales by Geographic Region (2017-2022) & (K Pcs)
    Table 29. Global Friedreich Ataxia Drug Sales Market Share Geographic Region (2017-2022)
    Table 30. Global Friedreich Ataxia Drug Revenue by Geographic Region (2017-2022) & ($ millions)
    Table 31. Global Friedreich Ataxia Drug Revenue Market Share by Geographic Region (2017-2022)
    Table 32. Global Friedreich Ataxia Drug Sales by Country/Region (2017-2022) & (K Pcs)
    Table 33. Global Friedreich Ataxia Drug Sales Market Share by Country/Region (2017-2022)
    Table 34. Global Friedreich Ataxia Drug Revenue by Country/Region (2017-2022) & ($ millions)
    Table 35. Global Friedreich Ataxia Drug Revenue Market Share by Country/Region (2017-2022)
    Table 36. Americas Friedreich Ataxia Drug Sales by Country (2017-2022) & (K Pcs)
    Table 37. Americas Friedreich Ataxia Drug Sales Market Share by Country (2017-2022)
    Table 38. Americas Friedreich Ataxia Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 39. Americas Friedreich Ataxia Drug Revenue Market Share by Country (2017-2022)
    Table 40. Americas Friedreich Ataxia Drug Sales by Type (2017-2022) & (K Pcs)
    Table 41. Americas Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)
    Table 42. Americas Friedreich Ataxia Drug Sales by Application (2017-2022) & (K Pcs)
    Table 43. Americas Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)
    Table 44. APAC Friedreich Ataxia Drug Sales by Region (2017-2022) & (K Pcs)
    Table 45. APAC Friedreich Ataxia Drug Sales Market Share by Region (2017-2022)
    Table 46. APAC Friedreich Ataxia Drug Revenue by Region (2017-2022) & ($ Millions)
    Table 47. APAC Friedreich Ataxia Drug Revenue Market Share by Region (2017-2022)
    Table 48. APAC Friedreich Ataxia Drug Sales by Type (2017-2022) & (K Pcs)
    Table 49. APAC Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)
    Table 50. APAC Friedreich Ataxia Drug Sales by Application (2017-2022) & (K Pcs)
    Table 51. APAC Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)
    Table 52. Europe Friedreich Ataxia Drug Sales by Country (2017-2022) & (K Pcs)
    Table 53. Europe Friedreich Ataxia Drug Sales Market Share by Country (2017-2022)
    Table 54. Europe Friedreich Ataxia Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 55. Europe Friedreich Ataxia Drug Revenue Market Share by Country (2017-2022)
    Table 56. Europe Friedreich Ataxia Drug Sales by Type (2017-2022) & (K Pcs)
    Table 57. Europe Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)
    Table 58. Europe Friedreich Ataxia Drug Sales by Application (2017-2022) & (K Pcs)
    Table 59. Europe Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)
    Table 60. Middle East & Africa Friedreich Ataxia Drug Sales by Country (2017-2022) & (K Pcs)
    Table 61. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Country (2017-2022)
    Table 62. Middle East & Africa Friedreich Ataxia Drug Revenue by Country (2017-2022) & ($ Millions)
    Table 63. Middle East & Africa Friedreich Ataxia Drug Revenue Market Share by Country (2017-2022)
    Table 64. Middle East & Africa Friedreich Ataxia Drug Sales by Type (2017-2022) & (K Pcs)
    Table 65. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Type (2017-2022)
    Table 66. Middle East & Africa Friedreich Ataxia Drug Sales by Application (2017-2022) & (K Pcs)
    Table 67. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)
    Table 68. Key Market Drivers & Growth Opportunities of Friedreich Ataxia Drug
    Table 69. Key Market Challenges & Risks of Friedreich Ataxia Drug
    Table 70. Key Industry Trends of Friedreich Ataxia Drug
    Table 71. Friedreich Ataxia Drug Raw Material
    Table 72. Key Suppliers of Raw Materials
    Table 73. Friedreich Ataxia Drug Distributors List
    Table 74. Friedreich Ataxia Drug Customer List
    Table 75. Global Friedreich Ataxia Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 76. Global Friedreich Ataxia Drug Sales Market Forecast by Region
    Table 77. Global Friedreich Ataxia Drug Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 78. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Region (2023-2028)
    Table 79. Americas Friedreich Ataxia Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 80. Americas Friedreich Ataxia Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 81. APAC Friedreich Ataxia Drug Sales Forecast by Region (2023-2028) & (K Pcs)
    Table 82. APAC Friedreich Ataxia Drug Revenue Forecast by Region (2023-2028) & ($ millions)
    Table 83. Europe Friedreich Ataxia Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 84. Europe Friedreich Ataxia Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 85. Middle East & Africa Friedreich Ataxia Drug Sales Forecast by Country (2023-2028) & (K Pcs)
    Table 86. Middle East & Africa Friedreich Ataxia Drug Revenue Forecast by Country (2023-2028) & ($ millions)
    Table 87. Global Friedreich Ataxia Drug Sales Forecast by Type (2023-2028) & (K Pcs)
    Table 88. Global Friedreich Ataxia Drug Sales Market Share Forecast by Type (2023-2028)
    Table 89. Global Friedreich Ataxia Drug Revenue Forecast by Type (2023-2028) & ($ Millions)
    Table 90. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Type (2023-2028)
    Table 91. Global Friedreich Ataxia Drug Sales Forecast by Application (2023-2028) & (K Pcs)
    Table 92. Global Friedreich Ataxia Drug Sales Market Share Forecast by Application (2023-2028)
    Table 93. Global Friedreich Ataxia Drug Revenue Forecast by Application (2023-2028) & ($ Millions)
    Table 94. Global Friedreich Ataxia Drug Revenue Market Share Forecast by Application (2023-2028)
    Table 95. Adverum Biotechnologies Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 96. Adverum Biotechnologies Inc Friedreich Ataxia Drug Product Offered
    Table 97. Adverum Biotechnologies Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 98. Adverum Biotechnologies Inc Main Business
    Table 99. Adverum Biotechnologies Inc Latest Developments
    Table 100. BioMarin Pharmaceutical Inc. Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 101. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Product Offered
    Table 102. BioMarin Pharmaceutical Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 103. BioMarin Pharmaceutical Inc. Main Business
    Table 104. BioMarin Pharmaceutical Inc. Latest Developments
    Table 105. Biovista Inc. Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 106. Biovista Inc. Friedreich Ataxia Drug Product Offered
    Table 107. Biovista Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 108. Biovista Inc. Main Business
    Table 109. Biovista Inc. Latest Developments
    Table 110. Cardero Therapeutics Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 111. Cardero Therapeutics Inc Friedreich Ataxia Drug Product Offered
    Table 112. Cardero Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 113. Cardero Therapeutics Inc Main Business
    Table 114. Cardero Therapeutics Inc Latest Developments
    Table 115. Catabasis Pharmaceuticals, Inc. Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 116. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Product Offered
    Table 117. Catabasis Pharmaceuticals, Inc. Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 118. Catabasis Pharmaceuticals, Inc. Main Business
    Table 119. Catabasis Pharmaceuticals, Inc. Latest Developments
    Table 120. Forward Pharma A/S Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 121. Forward Pharma A/S Friedreich Ataxia Drug Product Offered
    Table 122. Forward Pharma A/S Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 123. Forward Pharma A/S Main Business
    Table 124. Forward Pharma A/S Latest Developments
    Table 125. Ixchel Pharma LLC Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 126. Ixchel Pharma LLC Friedreich Ataxia Drug Product Offered
    Table 127. Ixchel Pharma LLC Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 128. Ixchel Pharma LLC Main Business
    Table 129. Ixchel Pharma LLC Latest Developments
    Table 130. Pfizer Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 131. Pfizer Inc Friedreich Ataxia Drug Product Offered
    Table 132. Pfizer Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 133. Pfizer Inc Main Business
    Table 134. Pfizer Inc Latest Developments
    Table 135. ProQR Therapeutics NV Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 136. ProQR Therapeutics NV Friedreich Ataxia Drug Product Offered
    Table 137. ProQR Therapeutics NV Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 138. ProQR Therapeutics NV Main Business
    Table 139. ProQR Therapeutics NV Latest Developments
    Table 140. RaNA Therapeutics Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 141. RaNA Therapeutics Inc Friedreich Ataxia Drug Product Offered
    Table 142. RaNA Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 143. RaNA Therapeutics Inc Main Business
    Table 144. RaNA Therapeutics Inc Latest Developments
    Table 145. Reata Pharmaceuticals Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 146. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Product Offered
    Table 147. Reata Pharmaceuticals Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 148. Reata Pharmaceuticals Inc Main Business
    Table 149. Reata Pharmaceuticals Inc Latest Developments
    Table 150. Retrotope Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 151. Retrotope Inc Friedreich Ataxia Drug Product Offered
    Table 152. Retrotope Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 153. Retrotope Inc Main Business
    Table 154. Retrotope Inc Latest Developments
    Table 155. Takeda Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 156. Takeda Friedreich Ataxia Drug Product Offered
    Table 157. Takeda Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 158. Takeda Main Business
    Table 159. Takeda Latest Developments
    Table 160. STATegics Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 161. STATegics Inc Friedreich Ataxia Drug Product Offered
    Table 162. STATegics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 163. STATegics Inc Main Business
    Table 164. STATegics Inc Latest Developments
    Table 165. Voyager Therapeutics Inc Basic Information, Friedreich Ataxia Drug Manufacturing Base, Sales Area and Its Competitors
    Table 166. Voyager Therapeutics Inc Friedreich Ataxia Drug Product Offered
    Table 167. Voyager Therapeutics Inc Friedreich Ataxia Drug Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)
    Table 168. Voyager Therapeutics Inc Main Business
    Table 169. Voyager Therapeutics Inc Latest Developments
List of Figures
    Figure 1. Picture of Friedreich Ataxia Drug
    Figure 2. Friedreich Ataxia Drug Report Years Considered
    Figure 3. Research Objectives
    Figure 4. Research Methodology
    Figure 5. Research Process and Data Source
    Figure 6. Global Friedreich Ataxia Drug Sales Growth Rate 2017-2028 (K Pcs)
    Figure 7. Global Friedreich Ataxia Drug Revenue Growth Rate 2017-2028 ($ Millions)
    Figure 8. Friedreich Ataxia Drug Sales by Region (2021 & 2028) & ($ millions)
    Figure 9. Product Picture of ADVM-063
    Figure 10. Product Picture of AGIL-FA
    Figure 11. Product Picture of BHV-4157
    Figure 12. Product Picture of BVA-202
    Figure 13. Product Picture of Others
    Figure 14. Global Friedreich Ataxia Drug Sales Market Share by Type in 2021
    Figure 15. Global Friedreich Ataxia Drug Revenue Market Share by Type (2017-2022)
    Figure 16. Friedreich Ataxia Drug Consumed in Clinic
    Figure 17. Global Friedreich Ataxia Drug Market: Clinic (2017-2022) & (K Pcs)
    Figure 18. Friedreich Ataxia Drug Consumed in Hospital
    Figure 19. Global Friedreich Ataxia Drug Market: Hospital (2017-2022) & (K Pcs)
    Figure 20. Friedreich Ataxia Drug Consumed in Others
    Figure 21. Global Friedreich Ataxia Drug Market: Others (2017-2022) & (K Pcs)
    Figure 22. Global Friedreich Ataxia Drug Sales Market Share by Application (2017-2022)
    Figure 23. Global Friedreich Ataxia Drug Revenue Market Share by Application in 2021
    Figure 24. Friedreich Ataxia Drug Revenue Market by Company in 2021 ($ Million)
    Figure 25. Global Friedreich Ataxia Drug Revenue Market Share by Company in 2021
    Figure 26. Global Friedreich Ataxia Drug Sales Market Share by Geographic Region (2017-2022)
    Figure 27. Global Friedreich Ataxia Drug Revenue Market Share by Geographic Region in 2021
    Figure 28. Global Friedreich Ataxia Drug Sales Market Share by Region (2017-2022)
    Figure 29. Global Friedreich Ataxia Drug Revenue Market Share by Country/Region in 2021
    Figure 30. Americas Friedreich Ataxia Drug Sales 2017-2022 (K Pcs)
    Figure 31. Americas Friedreich Ataxia Drug Revenue 2017-2022 ($ Millions)
    Figure 32. APAC Friedreich Ataxia Drug Sales 2017-2022 (K Pcs)
    Figure 33. APAC Friedreich Ataxia Drug Revenue 2017-2022 ($ Millions)
    Figure 34. Europe Friedreich Ataxia Drug Sales 2017-2022 (K Pcs)
    Figure 35. Europe Friedreich Ataxia Drug Revenue 2017-2022 ($ Millions)
    Figure 36. Middle East & Africa Friedreich Ataxia Drug Sales 2017-2022 (K Pcs)
    Figure 37. Middle East & Africa Friedreich Ataxia Drug Revenue 2017-2022 ($ Millions)
    Figure 38. Americas Friedreich Ataxia Drug Sales Market Share by Country in 2021
    Figure 39. Americas Friedreich Ataxia Drug Revenue Market Share by Country in 2021
    Figure 40. United States Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 41. Canada Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 42. Mexico Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 43. Brazil Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 44. APAC Friedreich Ataxia Drug Sales Market Share by Region in 2021
    Figure 45. APAC Friedreich Ataxia Drug Revenue Market Share by Regions in 2021
    Figure 46. China Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 47. Japan Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 48. South Korea Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 49. Southeast Asia Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 50. India Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 51. Australia Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 52. Europe Friedreich Ataxia Drug Sales Market Share by Country in 2021
    Figure 53. Europe Friedreich Ataxia Drug Revenue Market Share by Country in 2021
    Figure 54. Germany Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 55. France Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 56. UK Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 57. Italy Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 58. Russia Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 59. Middle East & Africa Friedreich Ataxia Drug Sales Market Share by Country in 2021
    Figure 60. Middle East & Africa Friedreich Ataxia Drug Revenue Market Share by Country in 2021
    Figure 61. Egypt Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 62. South Africa Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 63. Israel Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 64. Turkey Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 65. GCC Country Friedreich Ataxia Drug Revenue Growth 2017-2022 ($ Millions)
    Figure 66. Manufacturing Cost Structure Analysis of Friedreich Ataxia Drug in 2021
    Figure 67. Manufacturing Process Analysis of Friedreich Ataxia Drug
    Figure 68. Industry Chain Structure of Friedreich Ataxia Drug
    Figure 69. Channels of Distribution
    Figure 70. Distributors Profiles
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Please ask for Sample Report to see list of companies covered. Request Sample Report
Frequently Asked Questions
Global Friedreich Ataxia Drug Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Global Friedreich Ataxia Drug Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Global Friedreich Ataxia Drug Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports